Imaging Advances for Central Nervous System Tumors

Raymond Y Huang; Whitney B Pope

doi:10.1016/j.hoc.2021.08.002

Imaging Advances for Central Nervous System Tumors

Hematol Oncol Clin North Am. 2022 Feb;36(1):43-61. doi: 10.1016/j.hoc.2021.08.002. Epub 2021 Sep 23.

Authors

Raymond Y Huang¹, Whitney B Pope²

Affiliations

¹ Department of Neuroradiology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: ryhuang@bwh.harvard.edu.
² Radiology, Section of Neuroradiology, Brain Tumor Imaging, UCLA Medical Center, Los Angeles, CA, USA; Department of Radiological Sciences, David Geffen School of Medicine, University of California-Los Angeles, 924 Westwood Boulevard, Suite 615, Los Angeles, CA 90024, USA; Department of Neurology, David Geffen School of Medicine, University of California-Los Angeles, 924 Westwood Boulevard, Suite 615, Los Angeles, CA 90024, USA.

PMID: 34563433
DOI: 10.1016/j.hoc.2021.08.002

Abstract

This article reviews recent advances in the use of standard and advanced imaging techniques for diagnosis and treatment of central nervous system (CNS) tumors, including glioma and brain metastasis. Following the recent transition from a histology-based approach in classifying CNS tumors to one that integrates histology with the molecular information of tumor, the approaches for imaging CNS tumors have also been adapted to this new framework. Some challenges related to the diagnosis and treatment of CNS tumors, such as differentiating tumor from treatment-related imaging changes, require further progress to implement advanced imaging for clinical use.

Keywords: Diagnosis; Glioma; MRI; Metastasis; PET.

Publication types

Review

MeSH terms

Brain Neoplasms* / diagnostic imaging
Brain Neoplasms* / therapy
Central Nervous System Neoplasms* / diagnostic imaging
Central Nervous System Neoplasms* / therapy
Diagnostic Imaging
Glioma*
Humans